Sulfamethoxazole

CAS No.:723-46-6
Sulfamethoxazole is a broad-spectrum sulfonamide antibiotic with potent bacteriostatic activity against a wide range of Gram-positive and Gram-negative bacteria. As a key component in combination therapy with trimethoprim (co-trimoxazole), it is widely used for the treatment of urinary tract infections, respiratory tract infections, and opportunistic infections in immunocompromised patients. This high-purity Active Pharmaceutical Ingredient (API) is manufactured under strict cGMP standards, ensuring consistent quality and efficacy for pharmaceutical formulations.
Primary Applications:
1. Combination Therapy (Co-trimoxazole)
Urinary Tract Infections: Uncomplicated and complicated UTIs caused by susceptible organisms
Respiratory Tract Infections: Acute exacerbations of chronic bronchitis, acute otitis media, sinusitis
Gastrointestinal Infections: Shigellosis, typhoid fever
Skin and Soft Tissue Infections: Cellulitis, wound infections
2. Opportunistic Infections
Pneumocystis jirovecii Pneumonia (PCP): Prophylaxis and treatment in immunocompromised patients (HIV/AIDS, transplant recipients)
Toxoplasmosis: Treatment and prophylaxis
Nocardiosis: Treatment of systemic nocardiosis
3. Other Indications
Traveler's Diarrhea: Caused by enterotoxigenic E. coli
Cholera: Adjunctive therapy
Melioidosis: Treatment of systemic melioidosis
Package: 25kg/drum


Quickly Inquiry